Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Clinical trial NCT06845345 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06845345
Sponsor: Carmen Dietvorst
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Liver Fibrosis Liver Steatoses Hepatic Steatosis Hepatic Fibrosis Overweight or Obesity MASLD MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Cardio-metabolic Risk Cardio-metabolic Health Hypertension Dyslipidaemia

Start date: 2025-04-14
Primary completion: 2027-07-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.